Thyrotoxicosis and Heart Failure – a Case Report

1 Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368–78. ZiaeianB FonarowGC Epidemiology and aetiology of heart failure Nat Rev Cardiol 2016 13 6 368 78 10.1038/nrcardio.2016.25486877926935038 Search in Google Scholar

2 Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200. PonikowskiP VoorsAA AnkerSD 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur Heart J 2016 37 27 2129 200 10.1002/ejhf.59227207191 Search in Google Scholar

3 Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the Heart. Methodist Debakey Cardiovasc J. 2017;13(2):60–3. OsunaPM UdovcicM SharmaMD Hyperthyroidism and the Heart Methodist Debakey Cardiovasc J 2017 13 2 60 3 10.14797/mdcj-13-2-60551268028740583 Search in Google Scholar

4 Danzi S, Klein I. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin North Am. 2014;43(2):517–28. DanziS KleinI Thyroid disease and the cardiovascular system Endocrinol Metab Clin North Am 2014 43 2 517 28 10.1016/j.ecl.2014.02.00524891175 Search in Google Scholar

5 Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin e Investig en Arterioscler. 2014;26(6):296–309. Vargas-UricoecheaH Bonelo-PerdomoA Sierra-TorresCH Effects of thyroid hormones on the heart Clin e Investig en Arterioscler 2014 26 6 296 309 10.1016/j.arteri.2014.07.00325438971 Search in Google Scholar

6 Ellis ER, Josephson ME. What About Tachycardia-induced Cardiomyopathy? Arrhythmia Electrophysiol Rev. 2013;2(2):82–90. EllisER JosephsonME What About Tachycardia-induced Cardiomyopathy? Arrhythmia Electrophysiol Rev 2013 2 2 82 90 10.15420/aer.2013.2.2.82471157326835045 Search in Google Scholar

7 Collet J-P, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020:ehaa575. ColletJ-P ThieleH BarbatoE 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 2020 ehaa575 10.1093/eurheartj/ehaa90933186459 Search in Google Scholar

8 Her K, Choi CW, Park YW, Shin HK, Won YS. Concomitant Peripheral Artery Disease and Asymptomatic Coronary Artery Disease: A Management Strategy. Ann Vasc Surg. 2008;22(5):649–56. HerK ChoiCW ParkYW ShinHK WonYS Concomitant Peripheral Artery Disease and Asymptomatic Coronary Artery Disease: A Management Strategy Ann Vasc Surg 2008 22 5 649 56 10.1016/j.avsg.2008.01.01018504099 Search in Google Scholar

9 Adán V, Crown LA. Diagnosis and treatment of sick sinus syndrome. Am Fam Physician. 2003;67(8):1725–32. AdánV CrownLA Diagnosis and treatment of sick sinus syndrome Am Fam Physician 2003 67 8 1725 32 Search in Google Scholar

10 Klaeboe LG, Edvardsen T. Echocardiographic assessment of left ventricular systolic function. J Echocardiogr. 2019;17(1):10–6. KlaeboeLG EdvardsenT Echocardiographic assessment of left ventricular systolic function J Echocardiogr 2019 17 1 10 6 10.1007/s12574-018-0405-530390189 Search in Google Scholar

11 Kusunose K, Torii Y, Yamada H, et al. Clinical Utility of Longitudinal Strain to Predict Functional Recovery in Patients With Tachyarrhythmia and Reduced LVEF. JACC Cardiovasc Imaging. 2017;10(2):118–26. KusunoseK ToriiY YamadaH Clinical Utility of Longitudinal Strain to Predict Functional Recovery in Patients With Tachyarrhythmia and Reduced LVEF JACC Cardiovasc Imaging 2017 10 2 118 26 10.1016/j.jcmg.2016.03.01927665160 Search in Google Scholar

12 Han FT, Kiser R, Nixon J V., Wood MA, Ellenbogen KA. What is the time course of reversal of tachycardia-induced cardiomyopathy? Europace. 2011;13(1):139–41. HanFT KiserR NixonJ V. WoodMA EllenbogenKA What is the time course of reversal of tachycardia-induced cardiomyopathy? Europace 2011 13 1 139 41 10.1093/europace/euq29820682551 Search in Google Scholar

13 Mueller KAL, Heinzmann D, Klingel K, et al. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol. 2017;69(17):2160–72. MuellerKAL HeinzmannD KlingelK Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy J Am Coll Cardiol 2017 69 17 2160 72 10.1016/j.jacc.2017.02.04928449778 Search in Google Scholar

14 Addison D, Farhad H, Shah R V., et al. Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation. J Am Heart Assoc. 2016;5(9):e003570. AddisonD FarhadH ShahR V. Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation J Am Heart Assoc 2016 5 9 e003570 10.1161/JAHA.116.003570507902227671316 Search in Google Scholar

15 Neilan TG, Shah R V., Abbasi SA, et al. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation. J Am Coll Cardiol. 2013;62(23):2205–14. NeilanTG ShahR V. AbbasiSA The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation J Am Coll Cardiol 2013 62 23 2205 14 10.1016/j.jacc.2013.07.067390887223994399 Search in Google Scholar

16 Curtis AB, Worley SJ, Adamson PB, et al. Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction. N Engl J Med. 2013;368(17):1585–93. CurtisAB WorleySJ AdamsonPB Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction N Engl J Med 2013 368 17 1585 93 10.1056/NEJMoa121035623614585 Search in Google Scholar

17 Gasparini M, Leclercq C, Lunati M, et al. Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation. The CERTIFY Study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). JACC Hear Fail. 2013;1(6):500–7. GaspariniM LeclercqC LunatiM Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation. The CERTIFY Study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry) JACC Hear Fail 2013 1 6 500 7 10.1016/j.jchf.2013.06.00324622002 Search in Google Scholar

18 Watanabe H, Okamura K, Chinushi M, et al. Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy. Int Heart J. 2008;49(1):39–47. WatanabeH OkamuraK ChinushiM Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy Int Heart J 2008 49 1 39 47 10.1536/ihj.49.3918360063 Search in Google Scholar